Skip to main content

Table 1 Examples of homologies between tumor-associate antigens (TAAs) and viral antigens

From: Molecular mimicry and cancer vaccine development

HOMOLOGY BETWEEN TAAs AND VIRAL ANTIGENS

CANCER TYPE

TAA

MoA

HLA

Evidence

Reference

Melanoma

MART-127−35

AAGIGILTV

HSV-1

GIGIGVLAA

A*02:01

Cross-reactive CTL in melanoma patients

[39]

MART-126−35

EAAGIGILTV

Pseudorabies virus

VIAGIGILAI

A*02:01

Cross-reactive CTL in melanoma patients

[41, 42]

Variola virus

MIAGIGISLI

A*02:01

Lung ca.

TMEM161A

ALGGLLTPL

EBV

CLGGLLTMV

A*02:01

Cross-reactive CTL in lung cancer patients

[43]

Melanoma

Gp100

MLGTHTMEV

HCMV

MLGTHAMLV

A*02:01

Cross-reactive T cells in ex vivo experiments

[48]

Multiple ca.

CD274

LLNAFTVTV

HIV-1

LLNAFAIAV

A*02:01

Liver ca.

HEPACAM

RLAPFVYLL

Encephal. virus

RLAPFGYKI

A*02:01

Gut ca.

CEA

IMIGVLVGV

HIV-1

IMVGALIGV

A*02:01

Multiple ca.

TELOMERASE

RLVDDFLLV

HIV-1

RLVDEFLAI

A*02:01

Liver ca.

ISG15

MLAGNEFQV

Calicivirus

MLAGNAFTA

A*02:01

Cross-reactive T cells in ex vivo experiments

[49]

MDK

ALLALTSAV

HCV

ALMAFTSAV

A*02:01

MDK

LLLTLLALL

Adenovirus

LLLTLLLLL

A*02:01

C1QTNF12

LLGPQLVLL

HBV

LLGPLLVLL

A*02:01

Breast ca.

CCR9

AIADLLFLV

HIV-1

RLRDLLFLV

A*02:01

Cross-reactive T cells in ex vivo experiments

[50]

Colon ca.

EPCAM

VVAGIVVLV

VVAGIIALV

A*02:01

Brain ca.

DPYSL2

IPRRTTQRI

IPRRIRQRI

B*07:02

Lung ca.

CNIH4

LLNLPVATW

HCNLSVATW

B*58:01

Prostate ca.

NDUFS2

VSDGSSRPY

SSDNSSRPY

A*01:01